Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304).

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice.

ESMO open·2023

Same author

Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study.

Cancer epidemiology·2021

Same author

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

Does Increasing Packing Density Using Larger Caliber Coils Improve Angiographic Results of Embolization of Intracranial Aneurysms at 1 Year: A Randomized Trial.

AJNR. American journal of neuroradiology·2020

Same author

Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Current oncology (Toronto, Ont.)·2019

Same journal

The paradox of peer review: protecting science or policing thought?

Internal medicine journal·2026

Same journal

Immune-related pancytopenia in pregnancy.

Internal medicine journal·2026

Same journal

Crossover effect: causal machine learning reveals opposing mortality responses to mean arterial pressure targets among phenotypically distinct hypertensive patients with septic shock.

Internal medicine journal·2026

Same journal

Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral-treated human immunodeficiency virus infection.

Internal medicine journal·2026

Same journal

Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors.

Internal medicine journal·2026

Same journal

A scoping review of specialist hypertension clinics.

Internal medicine journal·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 30, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Prostate cancer: measuring PSA.

C Pezaro¹, H H Woo, I D Davis

¹Monash University Eastern Health Clinical School, Melbourne, Victoria, Australia.

Internal Medicine Journal

|May 13, 2014

Summary

This summary is machine-generated.

Prostate-specific antigen (PSA) screening for prostate cancer remains controversial. This review examines the evidence and recommendations for PSA

Keywords:

monitoring prostate cancer prostate-specific antigen (PSA)risk assessment screening

More Related Videos

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

Related Experiment Videos

Last Updated: Apr 30, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

Area of Science:

Oncology
Urology
Medical Diagnostics

Background:

Prostate-specific antigen (PSA) is utilized in prostate cancer management, including screening, risk assessment, and monitoring disease recurrence or advanced stages.
Significant limitations and ongoing debate exist regarding PSA-based decision-making in prostate cancer care.

Purpose of the Study:

To review the current evidence on the use of PSA in prostate cancer detection.
To summarize existing recommendations for PSA application in prostate cancer management.

Main Methods:

Literature review of studies and guidelines related to PSA testing in prostate cancer.
Synthesis of evidence regarding the efficacy and limitations of PSA in various clinical scenarios.

Main Results:

The review highlights the complex role of PSA testing, acknowledging its utility but also its significant shortcomings.
Evidence supporting PSA's effectiveness in population-wide screening is debated, necessitating careful interpretation of results.

Conclusions:

Current evidence necessitates a nuanced approach to PSA screening and management of prostate cancer.
Further research and updated guidelines are crucial for optimizing the use of PSA in clinical practice.